Wanwei Wang
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
-
- MicroRNA in disease regulation 3
- Surgery 6
- Esophageal Cancer Research and Treatment 6
- Co-authors
- Weiguo Zhu (7 shared papers)Guangzhou Tao (6 shared papers)Xi‐Lei Zhou (4 shared papers)Yu‐Suo Tong (3 shared papers)Xiufeng Cao (1 shared paper)Song YaQi (3 shared papers)Fu-Zhi Ji (1 shared paper)Lili Yang (1 shared paper)
- Journals
- Oncotarget (3 papers)JAMA Network Open (1 paper)Pathology & Oncology Research (1 paper)JAMA Oncology (1 paper)Molecular Therapy — Oncolytics (1 paper)
- Partner nations
- China
In The Last Decade
Wanwei Wang
15 papers receiving 395 citations
Peers
Comparison fields: 5 of 40
- Cancer Research 109
- Otorhinolaryngology 28
- Surgery 158
- Molecular Biology 155
- Pulmonary and Respiratory Medicine 64
Countries citing papers authored by Wanwei Wang
This map shows the geographic impact of Wanwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanwei Wang more than expected).
Fields of papers citing papers by Wanwei Wang
This network shows the impact of papers produced by Wanwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanwei Wang. The network helps show where Wanwei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 76 | |
| 2 | 2021 | 72 | |
| 3 | 2022 | 70 | |
| 4 | 2020 | 38 | |
| 5 | 2014 | 38 | |
| 6 | 2015 | 24 | |
| 7 | 2018 | 21 | |
| 8 | 2021 | 15 | |
| 9 | 2015 | 10 | |
| 10 | 2016 | 9 | |
| 11 | 2016 | 7 | |
| 12 | 2022 | 7 | |
| 13 | 2025 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2015 | 4 | |
| 16 | 2015 | 0 | |
| 17 | 2026 | 0 |
About Wanwei Wang
Wanwei Wang is a scholar working on Cancer Research, Surgery, Immunology, Molecular Biology and Otorhinolaryngology, having authored 17 papers that have together received 400 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (6 papers), MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (2 papers), Extracellular vesicles in disease (2 papers), Galectins and Cancer Biology (2 papers), Studies on Chitinases and Chitosanases (1 paper), Cell Adhesion Molecules Research (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (109 citations), Otorhinolaryngology (28 citations), Surgery (158 citations), Molecular Biology (155 citations) and Pulmonary and Respiratory Medicine (64 citations). Wanwei Wang has collaborated with scholars based in China. Frequent co-authors include Weiguo Zhu, Guangzhou Tao, Xi‐Lei Zhou, Yu‐Suo Tong, Xiufeng Cao, Song YaQi, Fu-Zhi Ji, Lili Yang, Changhua Yu and Dongcheng He. Their work appears in journals such as Oncotarget, JAMA Network Open, Pathology & Oncology Research, JAMA Oncology and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.